Millipore Sigma Vibrant Logo

530196 Pladienolide B, Streptomyces sp. - CAS 445493-23-2 - Calbiochem

A cell-permeable inhibitor of mRNA splicing that directly target the splicesome-associated protein 130 and impair U2 small nuclear ribonucleoprotein (U2 snRNP) interaction with pre-mRNA.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-2-((S,2E,4E)-7-((2R,3R)-3-((2R,3S)-3-hydroxypentan-2-yl), Pla-B

Primary Target: SAP130, splicing factor SF3b subunit 3
530196
  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      CAS #Empirical Formula
      445493-23-2C₃₀H₄₈O₈
      Description
      OverviewA cell-permeable, antitumor macrolide that acts as a time- and dose-dependent inhibitor of mRNA splicing. Shown to directly target the splicesome-associated protein 130 (SAP130, splicing factor SF3b subunit 3) and impair U2 small nuclear ribonucleoprotein (U2 snRNP) interaction with pre-mRNA causing unspliced or incompletely spliced pre-mRNA accumulation and altered gene expression. Exhibits potent anti-proliferative effect on WiDr and DLD1 colon cancer cell lines (IC50 = 500 pM and 8.5 nM, respectively) and is reported to down-regulate hypoxia-induced VEGF gene expression (IC50 = 1.8 nM in U251 cells). Blocks cell cycle by arresting progression at both G1 and G2/M phases. However, it does not affect the proliferation of resistant type of WiDr and DLD1 cells bearing R1074H mutation in SF3B1 gene. Inhibits tumor growth in WiDr tumor bearing nude mice and in a BSY-1 xenograft murine model (~5 – 10 mg/kg/day).
      Catalogue Number530196
      Brand Family Calbiochem®
      Synonyms(2S,3S,6S,7R,10R,E)-7,10-dihydroxy-2-((S,2E,4E)-7-((2R,3R)-3-((2R,3S)-3-hydroxypentan-2-yl), Pla-B
      References
      ReferencesYokoi, A., et al. 2011. FEBS J. 278, 4870.
      O'Brien, K., et al. 2008. J. Biol. Chem. 283, 33147.
      Kotake, Y., et al. 2007. Nat. Chem. Biol. 9, 570.
      Mizui, T., et al. 2004. J. Antibiot. 57, 188.
      Sakai, T., et al. 2004. J. Antibiot. 57, 180.
      Sakai, T., et al. 2004. J. Antibiot. 57, 173.
      Product Information
      CAS number445493-23-2
      FormWhite solid
      Hill FormulaC₃₀H₄₈O₈
      Chemical formulaC₃₀H₄₈O₈
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetSAP130, splicing factor SF3b subunit 3
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      530196 0

      Documentation

      Pladienolide B, Streptomyces sp. - CAS 445493-23-2 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      References

      Reference overview
      Yokoi, A., et al. 2011. FEBS J. 278, 4870.
      O'Brien, K., et al. 2008. J. Biol. Chem. 283, 33147.
      Kotake, Y., et al. 2007. Nat. Chem. Biol. 9, 570.
      Mizui, T., et al. 2004. J. Antibiot. 57, 188.
      Sakai, T., et al. 2004. J. Antibiot. 57, 180.
      Sakai, T., et al. 2004. J. Antibiot. 57, 173.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision18-April-2014 JSW
      Synonyms(2S,3S,6S,7R,10R,E)-7,10-dihydroxy-2-((S,2E,4E)-7-((2R,3R)-3-((2R,3S)-3-hydroxypentan-2-yl), Pla-B
      DescriptionA cell-permeable, antitumor macrolide that acts as a time- and dose-dependent inhibitor of mRNA splicing. Shown to directly target the splicesome-associated protein 130 (SAP130, splicing factor SF3b subunit 3) and impair U2 small nuclear ribonucleoprotein (U2 snRNP) interaction with pre-mRNA causing unspliced or incompletely spliced pre-mRNA accumulation and altered gene expression. Exhibits potent anti-proliferative effect on WiDr and DLD1 colon cancer cell lines (IC50 = 500 pM and 8.5 nM, respectively) and is reported to down-regulate hypoxia-induced VEGF gene expression (IC50 = 1.8 nM in U251 cells). Blocks cell cycle by arresting progression at both G1 and G2/M phases. However, it does not affect the proliferation of resistant type of WiDr and DLD1 cells bearing R1074H mutation in SF3B1 gene. Inhibits tumor growth in WiDr tumor bearing nude mice and in a BSY-1 xenograft murine model (~5 – 10 mg/kg/day).
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number445493-23-2
      Chemical formulaC₃₀H₄₈O₈
      Purity≥95% by HPLC
      SolubilityDMSO (20 mg/ml). Use only fresh DMSO for reconstitution.
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesYokoi, A., et al. 2011. FEBS J. 278, 4870.
      O'Brien, K., et al. 2008. J. Biol. Chem. 283, 33147.
      Kotake, Y., et al. 2007. Nat. Chem. Biol. 9, 570.
      Mizui, T., et al. 2004. J. Antibiot. 57, 188.
      Sakai, T., et al. 2004. J. Antibiot. 57, 180.
      Sakai, T., et al. 2004. J. Antibiot. 57, 173.